Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Denver, CO
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Coral Springs, FL
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Coral Springs, FL
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Jacksonville, FL
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Miami, FL
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Orlando, FL
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Smyrna, GA
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Smyrna, GA
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Oak Brook, IL
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Oak Brook, IL
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Lafayette, IN
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Lafayette, IN
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Baltimore, MD
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Saint Charles, MO
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Saint Charles, MO
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Willingboro, NJ
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Willingboro, NJ
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Albuquerque, NM
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Fresh Meadows, NY
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Fresh Meadows, NY
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Rochester, NY
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Philadelphia, PA
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Austin, TX
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
Dallas, TX
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/25/2018
Clinical Research Facility
mi
from
San Antonio, TX
A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
A Study of Augmentation With LY2216684 for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/25/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Brooklyn, NY
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Garden Grove, CA
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Oakland, CA
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Oakland, CA
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Temecula, CA
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Temecula, CA
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Waterbury, CT
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Waterbury, CT
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Boca Raton, FL
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Fort Myers, FL
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
North Bay Village, FL
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
North Bay Village, FL
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Oakland Park, FL
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Oakland Park, FL
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Orlando, FL
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Shreveport, LA
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Lincoln, NE
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Marlton, NJ
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Marlton, NJ
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
New York, NY
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Staten Island, NY
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Cincinnati, OH
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Media, PA
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Media, PA
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Herndon, VA
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Herndon, VA
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Richmond, VA
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated:  3/26/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Everton Park,
A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
Status: Enrolling
Updated: 3/26/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Everton Park,
Click here to add this to my saved trials
fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBI
fMRI-neuronavigated Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depression Associated With Traumatic Brain Injury
Status: Enrolling
Updated:  3/26/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
fMRI-neuronavigated rTMS for the Treatment of Major Depression Associated With TBI
fMRI-neuronavigated Repetitive Transcranial Magnetic Stimulation for the Treatment of Major Depression Associated With Traumatic Brain Injury
Status: Enrolling
Updated: 3/26/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study for Participants With Major Depression
A Study of the Effects of LY2216684, a Selective Norepinephrine Reuptake Inhibitor (NERI), in the Treatment of Major Depression
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Orlando, FL
A Study for Participants With Major Depression
A Study of the Effects of LY2216684, a Selective Norepinephrine Reuptake Inhibitor (NERI), in the Treatment of Major Depression
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study for Participants With Major Depression
A Study of the Effects of LY2216684, a Selective Norepinephrine Reuptake Inhibitor (NERI), in the Treatment of Major Depression
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Prairie Village, KA
A Study for Participants With Major Depression
A Study of the Effects of LY2216684, a Selective Norepinephrine Reuptake Inhibitor (NERI), in the Treatment of Major Depression
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Prairie Village, KA
Click here to add this to my saved trials
A Study for Participants With Major Depression
A Study of the Effects of LY2216684, a Selective Norepinephrine Reuptake Inhibitor (NERI), in the Treatment of Major Depression
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Allentown, PA
A Study for Participants With Major Depression
A Study of the Effects of LY2216684, a Selective Norepinephrine Reuptake Inhibitor (NERI), in the Treatment of Major Depression
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
A Study for Participants With Major Depression
A Study of the Effects of LY2216684, a Selective Norepinephrine Reuptake Inhibitor (NERI), in the Treatment of Major Depression
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Media, PA
A Study for Participants With Major Depression
A Study of the Effects of LY2216684, a Selective Norepinephrine Reuptake Inhibitor (NERI), in the Treatment of Major Depression
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Media, PA
Click here to add this to my saved trials
A Study for Participants With Major Depression
A Study of the Effects of LY2216684, a Selective Norepinephrine Reuptake Inhibitor (NERI), in the Treatment of Major Depression
Status: Enrolling
Updated:  3/26/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Bucharest,
A Study for Participants With Major Depression
A Study of the Effects of LY2216684, a Selective Norepinephrine Reuptake Inhibitor (NERI), in the Treatment of Major Depression
Status: Enrolling
Updated: 3/26/2018
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Bucharest,
Click here to add this to my saved trials
Caregiver Burden and Distress in Hematopoeitic Stem Cell Transplant
The Impact of Hematopoeitic Stem Cell Transplantation on Primary Caregiver Level of Burden and Distress
Status: Enrolling
Updated:  3/27/2018
Northside Hospital
mi
from
Atlanta, GA
Caregiver Burden and Distress in Hematopoeitic Stem Cell Transplant
The Impact of Hematopoeitic Stem Cell Transplantation on Primary Caregiver Level of Burden and Distress
Status: Enrolling
Updated: 3/27/2018
Northside Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker
Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker
Status: Enrolling
Updated:  3/27/2018
Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker
Neural and Visual Responses to Light in Bipolar Disorder: A Novel Putative Biomarker
Status: Enrolling
Updated: 3/27/2018
Western Psychiatric Institute and Clinic
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression
Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients With Treatment Resistant Depression: A Double Blind Placebo Controlled Trial
Status: Enrolling
Updated:  3/27/2018
Cleveland Clinic Foundation Center for Behavioral Health
mi
from
Cleveland, OH
Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression
Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients With Treatment Resistant Depression: A Double Blind Placebo Controlled Trial
Status: Enrolling
Updated: 3/27/2018
Cleveland Clinic Foundation Center for Behavioral Health
mi
from
Cleveland, OH
Click here to add this to my saved trials
Psychosocial Issues and Bariatric Surgery
Psychosocial Issues and Bariatric Surgery
Status: Enrolling
Updated:  3/27/2018
Neuropsychiatric Research Institute
mi
from
Fargo, ND
Psychosocial Issues and Bariatric Surgery
Psychosocial Issues and Bariatric Surgery
Status: Enrolling
Updated: 3/27/2018
Neuropsychiatric Research Institute
mi
from
Fargo, ND
Click here to add this to my saved trials
Dichotic Listening as a Predictor of Medication Response in Depression
Dichotic Listening as a Predictor of Medication Response in Depression
Status: Enrolling
Updated:  3/29/2018
New York State Psychiatric Institute
mi
from
New York, NY
Dichotic Listening as a Predictor of Medication Response in Depression
Dichotic Listening as a Predictor of Medication Response in Depression
Status: Enrolling
Updated: 3/29/2018
New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials